Relationship Between Non-dipper Hypertension and Aortic Sclerosis in Hypertensive Patients
PDF

Original Research

Relationship Between Non-dipper Hypertension and Aortic Sclerosis in Hypertensive Patients

Bull Cardiovasc Acad 2024;2(2):37-42 DOI: 10.4274/kvbulten.galenos.2024.35220
, , , , , ,
PDF
Permissions

Abstract

Objective

Non-dipper blood pressure (NDBP) pattern is associated with end-organ damage and cardiovascular mortality. Predicting and managing the NDBP pattern can prevent cardiovascular adverse events.The study aims to investigate the relationship between NDBP pattern and aortic valve sclerosis (AVS) detected during routine echocardiography in hypertensive patients.

Material and Methods

A total of 222 patients using at least one antihypertensive drug were included in the study. The patients were divided into two groups as dipper and NDBP pattern according to ambulatory blood pressure monitoring (ABPM). NDBP pattern was defined as reducing night systolic BP by <10% compared to daytime systolic BP. Patients outside this definition were defined as dipper hypertensives. AVS was defined as the thickening or calcification in the semilunar cusps, without stenosis in transthoracic echocardiography.

Results

The average age of patients with the NDBP pattern was 68.21±6.22, while it was 66.80±5.38 for patients with dipper BP pattern (p=0.075). As a result of ABPM, dipper BP (45%) was detected in 100 patients, and NDBP (55%) was detected in 122 patients. AVS was detected in 39 patients (17.6%), and the majority of them were in the NDBP group (3.6% vs. 14%, p<0.001). As a result of multivariate regression analysis, the only independent predictor of the NDBP pattern was AVS (odds ratio =3,078, 95% confidence interval 1.280-7.403, p=0.012)

Conclusion

In hypertensive patients, AVS detected by transthoracic echocardiography is associated with NDBP. The presence of AVS may be an essential factor in the detection of the NDBP pattern, that is closely related to major cardiovascular events.

Keywords: Non-dipper blood pressure, aortic valve sclerosis, ambulatory blood pressure monitoring

References

1

Verdecchia P, Schillaci G, Guerrieri M, Gatteschi C, Benemio G, Boldrini F, et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation. 1990;81(2):528-536.

2

Ozdemir E, Yildirimturk O, Cengiz B, Yurdakul S, Aytekin S. Evaluation of carotid intima-media thickness and aortic elasticity in patients with nondipper hypertension. Echocardiography. 2014;31(5):663-668.

3

Portaluppi F, Montanari L, Massari M, Di Chiara V, Capanna M. Loss of nocturnal decline of blood pressure in hypertension due to chronic renal failure. Am J Hypertens. 1991;4(1 Pt 1):20-26.

4

García-Ortiz L, Gómez-Marcos MA, Martín-Moreiras J, González-Elena LJ, et al. Pulse pressure and nocturnal fall in blood pressure are predictors of vascular, cardiac and renal target organ damage in hypertensive patients (LOD-RISK study). Blood Press Monit. 2009;14(4):145-151.

5

Adar A, Onalan O, Cakan F, Akbay E, Karakaya E. Aortic Arch Calcification on Routine Chest Radiography is Strongly and Independently Associated with Non-Dipper Blood Pressure Pattern. Arq Bras Cardiol. 2020;114(1):109-117.

6

Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol. 1997;29(3):630-634.

7

Lindroos M, Kupari M, Heikkilä J, Tilvis R. Predictors of left ventricular mass in old age: an echocardiographic, clinical and biochemical investigation of a random population sample. Eur Heart J. 1994;15(6):769-780.

8

Boon A, Cheriex E, Lodder J, Kessels F. Cardiac valve calcification: characteristics of patients with calcification of the mitral annulus or aortic valve. Heart. 1997;78(5):472-474.

9

Olsen MH, Wachtell K, Bella JN, Gerdts E, Palmieri V, Nieminen MS, et al. Aortic valve sclerosis relates to cardiovascular events in patients with hypertension (a LIFE substudy). Am J Cardiol. 2005;95(1):132-136.

10

Antonini-Canterin F, Huang G, Cervesato E, Faggiano P, Pavan D, Piazza R, et al. Symptomatic aortic stenosis: does systemic hypertension play an additional role? Hypertension. 2003;41(6):1268-1272.

11

Erdoğan T, Cetin M, Kocaman SA, Durakoğlugil ME, Ergül E, Canga A. Aortic valve sclerosis is a high predictive marker of systemic endothelial dysfunction in hypertensive patients. Herz. 2013;38(8):915-921.

12

Antonini-Canterin F, Di Bello V, Di Salvo G, La Carrubba S, Bellieni G, Benedetto F, et al. Relation of carotid intima-media thickness and aortic valve sclerosis (from the ISMIR study [“Ispessimento Medio Intimale e Rischio Cardiovascolare”] of the Italian Society of Cardiovascular Echography). Am J Cardiol. 2009;103(11):1556-1561.

13

Mahabala C, Kamath P, Bhaskaran U, Pai ND, Pai AU. Antihypertensive therapy: nocturnal dippers and nondippers. Do we treat them differently? Vasc Health Risk Manag. 2013;9:125-133.

14

O’Brien KD. Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more). Arterioscler Thromb Vasc Biol. 2006;26(8):1721-1728.

15

Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O’Brien KD. Characterization of the early lesion of ‘degenerative’ valvular aortic stenosis. Histological and immunohistochemical studies. Circulation. 1994;90(2):844-853.

16

Otto CM. Valvular aortic stenosis: disease severity and timing of intervention. J Am Coll Cardiol. 2006;47(11):2141-2151.

17

Sverdlov AL, Ngo DT, Chapman MJ, Ali OA, Chirkov YY, Horowitz JD. Pathogenesis of aortic stenosis: not just a matter of wear and tear. Am J Cardiovasc Dis. 2011;1(2):185-199.

18

Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation. 2005;111(24):3316-3326.

19

Di Minno MND, Di Minno A, Ambrosino P, Songia P, Pepi M, Tremoli E, et al. Cardiovascular morbidity and mortality in patients with aortic valve sclerosis: A systematic review and meta-analysis. Int J Cardiol. 2018;260:138-144.

20

Schönenberger A, Winkelspecht B, Köhler H, Girndt M. High prevalence of aortic valve alterations in haemodialysis patients is associated with signs of chronic inflammation. Nephron Clin Pract. 2004;96(2):c48-c55.

21

Nightingale AK, Horowitz JD. Aortic sclerosis: not an innocent murmur but a marker of increased cardiovascular risk. Heart. 2005;91(11):1389-1393.

22

Yurdam FS, Kış M. The Predictive Role of Systemic Immune Inflammation Index to the Aortic Valve Calcification in the Elderly Population with Chronic Renal Failure. EJ Cardiovasc Med. 2023;11(1):11-16.